Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure and Classes01:25

Antibody Structure and Classes

7.7K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the use of absolute binding free energy in the fragment optimisation process.

Communications chemistry·2023
Same author

An adapted consensus protein design strategy for identifying globally optimal biotherapeutics.

mAbs·2022
Same author

ADMET Predictability at Boehringer Ingelheim: State-of-the-Art, and Do Bigger Datasets or Algorithms Make a Difference?

Molecular informatics·2021
Same author

Large scale relative protein ligand binding affinities using non-equilibrium alchemy.

Chemical science·2021
Same author

Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.

Journal of medicinal chemistry·2020
Same author

BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.

Journal of chemical information and modeling·2020

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.6K

Development of scoring functions for antibody sequence assessment and optimization.

Daniel Seeliger1

  • 1Departement of Lead Identification and Optimization Support, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany.

Plos One
|November 9, 2013
PubMed
Summary

This study developed a statistical approach using antibody sequence data to assess and optimize antibody properties. This method aids in developing better antibodies for future drugs by predicting human-like characteristics and reducing immunogenicity.

More Related Videos

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

12.9K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

13.8K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.6K
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

12.9K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

13.8K

Area of Science:

  • Biotechnology
  • Immunology
  • Computational Biology

Background:

  • Antibody development faces challenges due to mutations affecting critical properties like stability and solubility.
  • Current antibody generation methods lack the ability to optimize for biotechnological application requirements.
  • Predicting and optimizing antibody properties is crucial for developing effective future therapeutics.

Purpose of the Study:

  • To develop early assessment strategies for antibodies using a statistical approach based on public sequence data.
  • To create heuristic potentials for antibody framework regions to evaluate sequence properties.
  • To establish a computational method for antibody humanization and immunogenicity prediction.

Main Methods:

  • Utilized public antibody sequence databases for human and murine antibody sequences.
  • Developed position-dependent and conditional probability potentials for antibody framework regions.
  • Applied these potentials to assess antibody humanness and optimize sequences for reduced immunogenicity.

Main Results:

  • Heuristic potentials effectively distinguish between human and murine antibody sequences.
  • The developed potentials provide a measure of 'humaness' based on phenotypic pools, not just germline identity.
  • Antibody humanization was modeled as a mathematical optimization problem, yielding in-silico variants similar to native sequences.

Conclusions:

  • The statistical approach offers a powerful tool for early antibody assessment and optimization.
  • The developed potentials facilitate accurate prediction of antibody humanness and potential immunogenicity.
  • This method aids in designing antibodies with improved properties for biotechnological and therapeutic applications.